Condition or disease | Intervention/treatment |
---|---|
Peri-operative Mortality | Device: Low profile endoprothesis (Navion Medtronic, NBS Low Profile Bolton Terumo) |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 200 participants |
Observational Model: | Case-Only |
Time Perspective: | Other |
Target Follow-Up Duration: | 24 Months |
Official Title: | Mortality and Complications in Endovascular Procedures Performed With New Generation Low-profile Devices |
Actual Study Start Date : | October 1, 2019 |
Estimated Primary Completion Date : | August 1, 2020 |
Estimated Study Completion Date : | August 1, 2021 |
Group/Cohort | Intervention/treatment |
---|---|
Treated patients |
Device: Low profile endoprothesis (Navion Medtronic, NBS Low Profile Bolton Terumo)
Aortic aneurysm exclusion through endovascular procedure
|
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
Contact: Giovanni Tinelli | 0039 0630157205 | giovanni.tinelli@policlinicogemelli.it |
Italy | |
Fondazione Policlinico Universitario A. Gemelli IRCCS | Recruiting |
Roma, RM, Italy, 00167 | |
Contact: Giovanni Tinelli 0039 0630157205 giovanni.tinelli@policlinicogemelli.it |
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | July 9, 2019 | ||||
First Posted Date | July 11, 2019 | ||||
Last Update Posted Date | February 6, 2020 | ||||
Actual Study Start Date | October 1, 2019 | ||||
Estimated Primary Completion Date | August 1, 2020 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
Mortality [ Time Frame: 30 days ] Post-operative mortality (intra-operatory and up to 30 days post-surgery)
|
||||
Original Primary Outcome Measures | Same as current | ||||
Change History | |||||
Current Secondary Outcome Measures |
Complications [ Time Frame: 24 months ] Complications during follow-up
|
||||
Original Secondary Outcome Measures | Same as current | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | Mortality and Complications in Endovascular Procedures Performed With New Generation Low-profile Devices | ||||
Official Title | Mortality and Complications in Endovascular Procedures Performed With New Generation Low-profile Devices | ||||
Brief Summary | The aim of this study is to observe mortality and complications in procedures in which are used new generation low-profile endoprothesis. | ||||
Detailed Description | Not Provided | ||||
Study Type | Observational [Patient Registry] | ||||
Study Design | Observational Model: Case-Only Time Perspective: Other |
||||
Target Follow-Up Duration | 24 Months | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Non-Probability Sample | ||||
Study Population | Patients eligible for elective TEVAR treatable with low-profile endoprothesis | ||||
Condition | Peri-operative Mortality | ||||
Intervention | Device: Low profile endoprothesis (Navion Medtronic, NBS Low Profile Bolton Terumo)
Aortic aneurysm exclusion through endovascular procedure
|
||||
Study Groups/Cohorts | Treated patients
Intervention: Device: Low profile endoprothesis (Navion Medtronic, NBS Low Profile Bolton Terumo)
|
||||
Publications * | Not Provided | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Recruiting | ||||
Estimated Enrollment |
200 | ||||
Original Estimated Enrollment | Same as current | ||||
Estimated Study Completion Date | August 1, 2021 | ||||
Estimated Primary Completion Date | August 1, 2020 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender |
|
||||
Ages | Child, Adult, Older Adult | ||||
Accepts Healthy Volunteers | No | ||||
Contacts |
|
||||
Listed Location Countries | Italy | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT04016545 | ||||
Other Study ID Numbers | 30027/19 | ||||
Has Data Monitoring Committee | Not Provided | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement |
|
||||
Responsible Party | Dr. Tinelli, Fondazione Policlinico Universitario Agostino Gemelli IRCCS | ||||
Study Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | ||||
Collaborators | Not Provided | ||||
Investigators | Not Provided | ||||
PRS Account | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | ||||
Verification Date | February 2020 |